TCL Archive Funding Opportunities: NIAID seeks New Investigator, Risky Research Proposals March 28, 1997
TCL Archive ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies June 5, 2009
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive DCT board Oks New Cooperative Groups For MRI Evaluations In Breast Cancer February 18, 1994